Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Prostate Cancer

  Free Subscription

Articles published in Acta Radiol

Retrieve available abstracts of 21 articles:
HTML format

Single Articles

    June 2021
  1. LINHARES MOREIRA AS, De Visschere P, Van Praet C, Villeirs G, et al
    How does PI-RADS v2.1 impact patient classification? A head-to-head comparison between PI-RADS v2.0 and v2.1.
    Acta Radiol. 2021;62:839-847.
    PubMed     Abstract available

    November 2020
  2. MAKELA P, Anttinen M, Suomi V, Steiner A, et al
    Acute and subacute prostate MRI findings after MRI-guided transurethral ultrasound ablation of prostate cancer.
    Acta Radiol. 2020 Nov 28:284185120976931. doi: 10.1177/0284185120976931.
    PubMed     Abstract available

    September 2020
  3. YANG L, Tan Y, Dan H, Hu L, et al
    Diagnostic performance of diffusion-weighted imaging combined with dynamic contrast-enhanced magnetic resonance imaging for prostate cancer: a systematic review and meta-analysis.
    Acta Radiol. 2020 Sep 9:284185120956269. doi: 10.1177/0284185120956269.
    PubMed     Abstract available

    August 2020
  4. KIM SH
    Determination of Gleason score discrepancy for risk stratification in magnetic resonance-ultrasound fusion prostate biopsy.
    Acta Radiol. 2020;61:1134-1142.
    PubMed     Abstract available

    July 2020
  5. GIANNARINI G, Cereser L, Como G, Bonato F, et al
    Accuracy of abbreviated multiparametric MRI-derived protocols in predicting local staging of prostate cancer in men undergoing radical prostatectomy.
    Acta Radiol. 2020 Jul 27:284185120943047. doi: 10.1177/0284185120943047.
    PubMed     Abstract available

  6. QUEIROZ MR, Falsarella PM, Moreira Valle LG, Cayres Mariotti G, et al
    Is a sampling transition zone important to increase the detection of prostate cancer in systematic prostatic biopsies?
    Acta Radiol. 2020 Jul 6:284185120938363. doi: 10.1177/0284185120938363.
    PubMed     Abstract available

    April 2020
  7. SHAISH H, Casals R, Ahmed F, Makkar J, et al
    Impact of mandated prospectively reported apparent diffusion coefficient values on the rates of positivity for clinically significant prostate cancer by PI-RADS score.
    Acta Radiol. 2020 Apr 20:284185120915617. doi: 10.1177/0284185120915617.

    February 2020
  8. LOSNEGARD A, Reisaeter LAR, Halvorsen OJ, Jurek J, et al
    Magnetic resonance radiomics for prediction of extraprostatic extension in non-favorable intermediate- and high-risk prostate cancer patients.
    Acta Radiol. 2020 Feb 28:284185120905066. doi: 10.1177/0284185120905066.

  9. JIANG Y, Li C, Liu Y, Shi K, et al
    Histogram analysis in prostate cancer: a comparison of diffusion kurtosis imaging model versus monoexponential model.
    Acta Radiol. 2020 Feb 2:284185120901504. doi: 10.1177/0284185120901504.

    December 2019
  10. PETERSEN LJ, Johansen MN, Strandberg J, Stenholt L, et al
    Reporting and handling of equivocal imaging findings in diagnostic studies of bone metastasis in prostate cancer.
    Acta Radiol. 2019 Dec 10:284185119890087. doi: 10.1177/0284185119890087.

    September 2019
  11. LEE CH
    Quantitative T2-mapping using MRI for detection of prostate malignancy: a systematic review of the literature.
    Acta Radiol. 2019;60:1181-1189.

    August 2019
  12. TULIPAN AJ, Hole KH, Vlatkovic L, Revheim ME, et al
    Localization of radio-recurrence within the prostate: anti-3-18F-FACBC PET/CT compared with multiparametric MRI using histopathology as reference standard.
    Acta Radiol. 2019;60:1028-1038.

    June 2019
  13. ARTEAGA-MARRERO N, Mainou-Gomez JF, Brekke Rygh C, Lutay N, et al
    Radiation treatment monitoring with DCE-US in CWR22 prostate tumor xenografts.
    Acta Radiol. 2019;60:788-797.
    PubMed     Abstract available

    March 2019
  14. ZHANG P, Min X, Wang L, Feng Z, et al
    Bi-exponential versus mono-exponential diffusion-weighted imaging for evaluating prostate cancer aggressiveness after radical prostatectomy: a whole-tumor histogram analysis.
    Acta Radiol. 2019 Mar 21:284185119837932. doi: 10.1177/0284185119837932.
    PubMed     Abstract available

    January 2018
  15. DYRBERG E, Larsen EL, Hendel HW, Thomsen HS, et al
    Diagnostic bone imaging in patients with prostate cancer: patient experience and acceptance of NaF-PET/CT, choline-PET/CT, whole-body MRI, and bone SPECT/CT.
    Acta Radiol. 2018 Jan 1:284185117751280. doi: 10.1177/0284185117751280.
    PubMed     Abstract available

  16. LI C, Chen M, Wan B, Yu J, et al
    A comparative study of Gaussian and non-Gaussian diffusion models for differential diagnosis of prostate cancer with in-bore transrectal MR-guided biopsy as a pathological reference.
    Acta Radiol. 2018 Jan 1:284185118760961. doi: 10.1177/0284185118760961.
    PubMed     Abstract available

  17. KARUNAMUNI RA, Kuperman J, Seibert TM, Schenker N, et al
    Relationship between kurtosis and bi-exponential characterization of high b-value diffusion-weighted imaging: application to prostate cancer.
    Acta Radiol. 2018 Jan 1:284185118770889. doi: 10.1177/0284185118770889.
    PubMed     Abstract available

    April 2017
  18. WOO S, Kim SY, Cho JY, Kim SH, et al
    Length of capsular contact on prostate MRI as a predictor of extracapsular extension: which is the most optimal sequence?
    Acta Radiol. 2017;58:489-497.
    PubMed     Abstract available

    January 2017
  19. GODLEY KC, Syer TJ, Toms AP, Smith TO, et al
    Accuracy of high b-value diffusion-weighted MRI for prostate cancer detection: a meta-analysis.
    Acta Radiol. 2017 Jan 1:284185117702181. doi: 10.1177/0284185117702181.
    PubMed     Abstract available

  20. BOESEN L, Norgaard N, Logager V, Balslev I, et al
    Multiparametric MRI in men with clinical suspicion of prostate cancer undergoing repeat biopsy: a prospective comparison with clinical findings and histopathology.
    Acta Radiol. 2017 Jan 1:284185117718400. doi: 10.1177/0284185117718400.
    PubMed     Abstract available

  21. ELKJAER MC, Andersen MH, Hoyer S, Pedersen BG, et al
    Prostate cancer: in-bore magnetic resonance guided biopsies at active surveillance inclusion improve selection of patients for active treatment.
    Acta Radiol. 2017 Jan 1:284185117723372. doi: 10.1177/0284185117723372.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.